Remove Confidentiality Remove Invention Remove Workshop
article thumbnail

SpicyIP Weekly Review (March 13- March 18)

SpicyIP

Workshop on ‘Patent Opposition in the Pharmaceutical Field’ [Kochi, April 24-28] We are pleased to announce that the Inter-University Centre for IPR Studies (IUCIPRS), CUSAT, and Third World Network are jointly organizing the 4th edition of their workshop on ‘Patent Opposition in the Pharmaceutical Field’ between April 24-28, 2023.

Art 104
article thumbnail

Back to Life (Sciences) in Amsterdam. A conference report

The IPKat

On the first day, during a workshop, reference was made to the expectation that Germany will file its instrument of ratification for the UPC on 1 st July 2022, which would then trigger the 3-months sunrise period for opt-outs and alike. The original conference program (which was only slightly amended due to some covid-related absences).

article thumbnail

Impact of other related Intellectual Property rights on the Pharmaceutical Industry

IIPRD

Introduction A “patent” is a right granted by a state to an inventor for a fixed period i.e., 20 years in India in exchange for the disclosure of the invention. The fundamental patentability criteria are universal namely: novelty, inventive step, non-obviousness and industrial applicability.